argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference
04 June 2024 - 3:00PM
June 4, 2024Amsterdam,
the Netherlands – argenx (Euronext & Nasdaq: ARGX), a
global immunology company committed to improving the lives of
people suffering from severe autoimmune diseases, today announced
that members of management will participate in a fireside chat at
the Goldman Sachs 45th Annual Global Healthcare Conference on
Tuesday, June 11, 2024 at 2:40 PM ET in Miami, FL.
A live webcast of the fireside chat may be
accessed on the Investors section of the argenx website at
argenx.com/investors. A replay of the webcast will be available on
the argenx website for approximately 90 days following the fireside
chat.
About argenx
argenx is a global immunology company committed
to improving the lives of people suffering from severe autoimmune
diseases. Partnering with leading academic researchers through its
Immunology Innovation Program (IIP), argenx aims to translate
immunology breakthroughs into a world-class portfolio of novel
antibody-based medicines. argenx developed and is commercializing
the first approved neonatal Fc receptor (FcRn) blocker, globally in
the U.S., Japan, Israel, the EU, the UK, China and Canada. The
Company is evaluating efgartigimod in multiple serious autoimmune
diseases and advancing several earlier stage experimental medicines
within its therapeutic franchises. For more information, visit
www.argenx.com and follow us on LinkedIn, X/Twitter, Instagram,
Facebook, and YouTube.
For further information, please contact:
Media:
Ben Petokbpetok@argenx.com
Investors:
Alexandra Roy (US)aroy@argenx.com
Lynn Elton (EU)lelton@argenx.com
Argen X (EU:ARGX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Argen X (EU:ARGX)
Historical Stock Chart
From Nov 2023 to Nov 2024
